• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    1/23/24 2:18:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    SC 13G/A 1 mlab10.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.10) Mesa Laboratories, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 59064R109 (CUSIP Number) Date of Event Which Requires Filing of this Statement: December 31, 2023 *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 59064R109 13G 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LP 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 269,645 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 269,645 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 269,645 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.% 12 TYPE OF REPORTING PERSON IA CUSIP No. 59064R109 13G Item 1(a) Name of Issuer: Mesa Laboratories, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: Chief Financial Officer 12100 West Sixth Avenue Lakewood, CO 80228 Item 2(a) Name of Persons Filing: Royce & Associates, LP Item 2(b) Address of Principal Business Office, or, if None, Residence: 745 Fifth Avenue, New York, NY 10151 Item 2(c) Citizenship: New York Corporation Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 59064R109 Item 3 If this statement is filed pursuant to rules 13d-1(b), or 13d- 2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Act (b) [ ] Bank as defined in Section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment Company registered under Section 8 of the Investment Company Act (e) [X] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund (g) [ ] Parent Holding Company, in accordance with Rule 13d-1 (b)(ii)(G) (h) [ ] Group CUSIP No. 59064R109 13G Item 4 Ownership The securities reported herein are beneficially owned by one or more registered investment companies or other managed accounts that are investment management clients of Royce & Associates, LP ("RALP"), an indirect majority owned subsidiary of Franklin Resources, Inc.("FRI"). When an investment management contract (including a sub advisory agreement) delegates to RALP investment discretion or voting power over the securities held in the investment advisory accounts that are subject to that agreement, FRI treats RALP as having sole investment discretion or voting authority, as the case may be, unless the agreement specifies otherwise. Accordingly, RALP reports on Schedule 13G that it has sole investment discretion and voting authority over the securities covered by any such investment management agreement, unless otherwise noted in this Item 4. As a result, for purposes of Rule 13d 3 under the Act, RALP may be deemed to be the beneficial owner of the securities reported in this Schedule 13G. Beneficial ownership by investment management subsidiaries and other affiliates of FRI is being reported in conformity with the guidelines articulated by the SEC staff in Release No. 34 39538 (January 12, 1998) relating to organizations, such as FRI, where related entities exercise voting and investment powers over the securities being reported independently from each other. The voting and investment powers held by RALP are exercised independently from FRI (RALP's parent holding company) and from all other investment management subsidiaries of FRI (FRI, its affiliates and investment management subsidiaries other than RALP are, collectively, "FRI affiliates"). Furthermore, internal policies and procedures of RALP and FRI affiliates establish informational barriers that prevent the flow between RALP and the FRI affiliates of information that relates to the voting and investment powers over the securities owned by their respective investment management clients. Consequently, RALP and the FRI affiliates report the securities over which they hold investment and voting power separately from each other for purposes of Section 13 of the Act. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") each own in excess of 10% of the outstanding common stock of FRI and are the principal stockholders of FRI. However, because RALP exercises voting and investment powers on behalf of its investment management clients independently of FRI affiliates, beneficial ownership of the securities reported by RALP is not attributed to the Principal Shareholders. RALP disclaims any pecuniary interest in any of the securities reported in this Schedule 13G. In addition, the filing of this Schedule 13G on behalf of RALP should not be construed as an admission that it is, and it disclaims that it is, the beneficial owner, as defined in Rule 13d 3, of any of such securities. Furthermore, RALP believes that it is not a "group" with FRI affiliates, the Principal Shareholders, or their respective affiliates within the meaning of Rule 13d 5 under the Act and that none of them is otherwise required to attribute to any other the beneficial ownership of the securities held by such person or by any persons or entities for whom or for which RALP or the FRI affiliates provide investment management services. (a) Amount Beneficially Owned: 269,645 (b) Percent of Class: 5.% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 269,645 (ii) shared power to vote or to direct the vote __________ (iii) sole power to dispose or to direct the disposition of 269,645 (iv) shared power to dispose or to direct the disposition of __________ Item 5 Ownership of Five Percent or Less of a Class. [ ] Item 6 Ownership of More than Five Percent on Behalf of Another Person. NONE Item 7 Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company. NOT APPLICABLE Item 8 Identification and Classification of Members of the Group. NOT APPLICABLE Item 9 Notice of Dissolution of Group. NOT APPLICABLE CUSIP No. 59064R109 13G Item 10 Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to it is true, complete and correct. Date: January 23, 2024 By: Daniel A. O'Byrne Vice President
    Get the next $MLAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Financials

    Live finance-specific insights

    See more
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

      1/6/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

      10/2/24 2:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    SEC Filings

    See more
    • Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      6/6/25 3:00:33 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Mesa Laboratories Inc.

      10-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:01:28 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:00:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    See more
    • Mesa Laboratories Appoints Mark Capone to its Board of Directors

      LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

      1/8/24 8:00:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

      LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

      11/4/22 3:49:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

      LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated and retired on May 2, 2022. With Mr. Tripeny's appointment, the Mesa Laboratories, Inc. Board of Directors will be comprised of eight directors, six of whom are independent. Mr. Tripeny is likely to be appointed to the Audit Committee and brings extensive financial experience to the Board. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent

      6/27/22 8:01:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      10/15/24 1:29:56 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      2/13/24 5:09:39 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      1/23/24 2:18:26 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • President and CEO Owens Gary M exercised 21,000 shares at a strike of $122.98 and sold $2,602,110 worth of shares (21,000 units at $123.91) (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      3/24/25 1:38:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,878 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      11/25/24 11:40:41 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • President and CEO Owens Gary M was granted 11,559 shares and sold $571,736 worth of shares (5,069 units at $112.79), increasing direct ownership by 18% to 43,337 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      10/29/24 8:18:57 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

      LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q25") and full fiscal year ("FY25") ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAAP adjusted operating income ("AOI") excluding unusual items2 decreased 18.0% and was 19.7% as a percentage of revenues   Full FY25 compared to full FY24:

      5/28/25 8:00:16 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Third Quarter Results

      LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter ("3Q25") ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted operating income excluding unusual items2 increased 13.3% and was 23.5% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"

      2/4/25 8:00:38 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Wells Fargo initiated coverage on Mesa Laboratories with a new price target

      Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

      8/28/24 7:48:06 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

      1/4/24 8:29:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials